Spire Wealth Management’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Spire Wealth Management's OGN Position: Q2 2026 in Review
Spire Wealth Management increased its Organon & Co (OGN) stake by 44% in Q2 2026, buying an estimated $454 and bringing the position to 124 shares worth $1.68K. The position accounts for ﹤0.01% of the portfolio, ranked #2037.
Spire Wealth Management first reported a position in OGN in Q2 2022 and has held it in 17 quarters since. The position peaked at $365K in Q2 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Spire Wealth Management held 124 shares of Organon & Co worth $1.68K as of Q2 2026.
- Spire Wealth Management bought 38 Organon & Co shares in Q2 2026, an estimated $454.
- Organon & Co made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #2037 holding.
- Spire Wealth Management first reported a position in Organon & Co in Q2 2022 and has held it in 17 quarters since.
- Spire Wealth Management's Organon & Co position peaked at $365K in Q2 2022.
- 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.